For the year ending 2025-12-31, MXCT made $33,026K in revenue. -$44,630K in net income. Net profit margin of -135.14%.
| Income Statement | 2025-12-31 | |||
|---|---|---|---|---|
| Revenue | 33,026 | |||
| Cost of goods sold | 6,222 | |||
| Gross profit | 26,804 | |||
| Research and development | 20,823 | |||
| Sales and marketing | 18,924 | |||
| General and administrative | 28,116 | |||
| Restructuring expense | 3,058 | |||
| Goodwill impairment | 3,554 | |||
| Depreciation and amortization | 4,226 | |||
| Total operating expenses | 78,701 | |||
| Operating loss | -51,897 | |||
| Interest income | 7,267 | |||
| Total other income | 7,267 | |||
| Loss before income taxes | -44,630 | |||
| Net loss | -44,630 | |||
| Basic EPS | -0.42 | |||
| Diluted EPS | -0.42 | |||
| Basic Average Shares | 106,427,854 | |||
| Diluted Average Shares | 106,427,854 | |||
MAXCYTE, INC. (MXCT)
MAXCYTE, INC. (MXCT)